Page 22 - Looking Statement News Today

20.09.2023 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application (sBLA) seeking approval for ...

EDISON, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Zerify Inc., (OTC PINK: ZRFY), the 22-year-old cybersecurity company focused on securing communications, collaboration and confidential data announced today that Aligned Risk

TORONTO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clear Blue Technologies International Inc. (

TORONTO, Sept. 20, 2023 -- Clear Blue Technologies International Inc. , announces that it has concluded a renewal and extension of its loan with BDC Capital. Concurrently, the Company is very...

Acceptance based on results from the Phase 3 LITESPARK-005 trial, which showed a statistically significant and clinically meaningful improvement in progression-free survival compared to everolimus in...

Avenir Wellness Solutions Announces Return of Stock Trading Back to ...

AsiaFIN Holdings Corp. (ASFH) Up-listed to OTCQB Venture Market

Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial ...

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) ("Hoth" or the "Company"), a patient-focused biopharmaceutical company, today announced the closing of...

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that HT-KIT, a new molecular entity, for...